Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DNA-PK-IN-8 is a potent, selective, and orally active inhibitor of DNA-dependent protein kinase (DNA-PK), demonstrating an IC50 value of 0.8 nM. It displays synergistic antiproliferative effects across various cancer cell lines and notably reduces HL-60 tumor growth when combined with Doxorubicin [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,520.00 | |
50 mg | 10-14 weeks | $ 1,980.00 | |
100 mg | 10-14 weeks | $ 2,500.00 |
Description | DNA-PK-IN-8 is a potent, selective, and orally active inhibitor of DNA-dependent protein kinase (DNA-PK), demonstrating an IC50 value of 0.8 nM. It displays synergistic antiproliferative effects across various cancer cell lines and notably reduces HL-60 tumor growth when combined with Doxorubicin [1]. |
In vitro | DNA-PK-IN-8 (compound DK1) effectively reduces γH2A.X expression in a concentration-dependent manner in HCT-116 cells when administered at concentrations of 1, 5, and 10 μM for an incubation period of 6 hours, following pre-treatment with Bleomycin. This effect was confirmed through immunofluorescence analysis in the specified cell line [1]. |
In vivo | DNA-PK-IN-8, administered orally at a dose of 100 mg/kg daily for 16 days, significantly inhibited HL-60 tumor growth in nude mice when used in conjunction with Doxorubicin, demonstrating tumor growth inhibition (TGI) values of 52.4% and 62.4% for tumor weight and volume, respectively. Additionally, a single oral dose of DNA-PK-IN-8 at 5 mg/kg in Sprague-Dawley rats revealed favorable pharmacokinetic properties, both in vitro and in vivo, supporting its potential as an oral therapeutic candidate. The pharmacokinetic analysis in Sprague-Dawley rats showed a maximum plasma concentration (Cmax) of 810 ± 122.32 ng/mL, achieved at a median time (Tmax) of 0.42 ± 0.11 hours, with a half-life (t1/2) of 1.59 ± 0.26 hours and an area under the curve (AUC 0-∞) of 3598.7 ± 769.81 ng/mL·h, indicating its reasonable pharmacokinetic profile. |
Molecular Weight | 394.43 |
Formula | C19H22N8O2 |
CAS No. | 2823369-81-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DNA-PK-IN-8 2823369-81-7 inhibitor inhibit